diaceutics_logo_withstrap_white
Investor Overview
  • Why Invest in Diaceutics?
  • Contacts
  • Advisers
  • Corporate Governance
  • Company Profile
  • Shareholder Information
  • Documents Sent to Shareholders
  • AIM Rule 26
  • Share Price Information
  • Analyst Research
Results & Reports
Regulatory Announcements
Board of Directors
ESG
Go to Diaceutics.com
diaceutics_logo_withstrap_white
  • Investor Overview
    • Why Invest in Diaceutics?
    • Contacts
    • Advisers
    • Corporate Governance
    • Company Profile
    • Shareholder Information
    • Documents Sent to Shareholders
    • AIM Rule 26
    • Share Price Information
    • Analyst Research
  • Results & Reports
  • Regulatory Announcements
  • Board of Directors
  • ESG
Contact Us
Investors
  • Go to Diaceutics.com
All Articles
Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces its unaudited interim results for the six months ended 30 June 2021.
Download Report
Interim Report June 2021

Interim Report June 2021

14 September, 2021

Contact our Experts Follow us on LinkedIn

Share

© Diaceutics PLC 2025

Contact Us Terms of Use Privacy Statement Cookie Settings